Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Oncothyreon obtains license to anticancer agents from Sanford-Burnham Medical Research Institute

Sep. 15, 2011

Ampio and Daewoong enter urology drug agreement in South Korea

Sep. 15, 2011

Ono Pharmaceutical enters agreement with Servier for ivabradine

Sep. 14, 2011

Seattle Genetics and Oxford BioTherapeutics form antibody-drug conjugate collaboration

Sep. 14, 2011

Hawthorn Pharmaceuticals and CoPlex Therapeutics enter licensing deal

Sep. 14, 2011

Juvaris and Colby Pharmaceutical enter agreement for CLDC technology and JVRS-100

Sep. 14, 2011

Merck & Co. and BGI join to discover and develop biomarkers and genomic technologies

Sep. 13, 2011

AtheroNova and Maxwell Biotech sign deal for AHRO-001

Sep. 13, 2011

Silence Therapeutics and InteRNA Technologies enter miRNA agreement

Sep. 12, 2011

Sucampo and Numab to collaborate in discovery of high-affinity antibodies

Sep. 12, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...